A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.

類似資料

• Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
  著者:: Miller, P, 等
  出版事項: (2005)
• Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
  著者:: Reginster, J, 等
  出版事項: (2006)
• The mobile study long-term extension: Progressive improvements in efficacy with oral ibandronate (150mg) when administered monthly
  著者:: Reginster, J, 等
  出版事項: (2007)
• Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
  著者:: Richard Derman, 等
  出版事項: (2009-09-01)
• Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
  著者:: Cranney, A, 等
  出版事項: (2009)